To view the PDF file, sign up for a MySharenet subscription.

ASPEN PHARMACARE HOLDINGS LIMITED - Dealing In Aspen Securities

Release Date: 28/11/2024 17:00
Code(s): APN     PDF:  
Wrap Text
Dealing In Aspen Securities

ASPEN PHARMACARE HOLDINGS LIMITED
(Incorporated in the Republic of South Africa) ("Aspen Holdings")
Registration number: 1985/002935/06
Share code: APN
ISIN: ZAE000066692
LEI: 635400ZYSN1IRD5QWQ94
("Aspen" or "the Company")

DEALING IN ASPEN SECURITIES

In compliance with the JSE Limited Listings Requirements, shareholders are advised of the following dealings
in Aspen's securities by a third-party intermediary ("the Intermediary").

A hedging transaction was entered into with the Intermediary to enable the Company to settle its future
obligation to employees participating in the SA Management Deferred Incentive Bonus Scheme ("the
Scheme") of Aspen and three of its wholly owned South African subsidiaries, namely Pharmacare Limited,
Aspen Finance (Pty) Limited and Fine Chemicals Corporation (Pty) Ltd. In terms of this hedging transaction
the Intermediary acquired Aspen shares as follows:

  Date of transaction:                  26 November 2024
  Nature and details of transaction     On-market purchase of securities to satisfy the future
  by intermediary:                      obligations towards participants of the Scheme
  Number of securities:                 367 662
  Purchase price:                       R169.00
  Total value of the transaction:       R62 134 878
  Class of securities:                  Ordinary Shares
  Nature of interest:                   Direct beneficial
  Clearance obtained:                   Yes




Durban
28 November 2024

Sponsor:
Investec Bank Limited

Date: 28-11-2024 05:00:00
Produced by the JSE SENS Department. The SENS service is an information dissemination service administered by the JSE Limited ('JSE'). 
The JSE does not, whether expressly, tacitly or implicitly, represent, warrant or in any way guarantee the truth, accuracy or completeness of
 the information published on SENS. The JSE, their officers, employees and agents accept no liability for (or in respect of) any direct, 
indirect, incidental or consequential loss or damage of any kind or nature, howsoever arising, from the use of SENS or the use of, or reliance on,
 information disseminated through SENS.